Trial
NCT00450333
Dynepo Infrequent Dosing Study
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Shire
Collaborators
—
Condition
Anemia
Intervention
Dynepo (Epoetin delta)
Why stopped
The termination of the study is not linked to a product recall or result of any safety signal. Rather it was sponsor's commercial decision to withdraw the MA
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-06-14